bremelanotide
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Bremelanotide is an injectable indicated for premenopausal women with hypoactive sexual desire disorder (HSDD).
INTRODUCTION:Bremelanotide, an investigational new drug, is a melanocortin 4 receptor agonist that has demonstrated efficacy in…
Metadoxine (pyridoxol L-2-pyrrolidone-5-carboxylate) is an ion-pair salt of pyridoxine (vitamin B6) and 2-pyrrolidone…
INTRODUCTION: Bremelanotide is a novel heptapeptide melanocortin receptor-4 agonist. This study examined its at-home, as-needed…
INTRODUCTION: Bremelanotide is a novel heptapeptide melanocortin receptor-4 agonist. This study examined its subcutaneous self…
The treatment of erectile dysfunction (ED) has been revolutionized in the last 15 years with the introduction of type 5…
The neurobiology of sexual behavior involves the interrelationships between sex steroids and neurotransmitters that result in…